Grace Therapeutics, Inc. (NASDAQ:GRCE) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 12, 2026. The Healthcare company reported Q0…
Grace Therapeutics, Inc. (NASDAQ:GRCE) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 12, 2026.
The Healthcare company reported Q0 revenue of .
Grace Therapeutics, Inc.'s stock currently trades at $3.53 with a market capitalization of $47.5M.
Current market data
NASDAQ · GRCE
$2.12
Down: -$0.01 · -0.47%
Live quote updated
Keep reading
sec_filing ·
sec_filing ·
earnings ·
sec_filing ·
